Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Single-Cell Analysis | 3 | 2024 | 2540 | 1.080 |
Why?
|
| Trophoblasts | 1 | 2024 | 223 | 0.820 |
Why?
|
| Arsenic | 1 | 2024 | 358 | 0.720 |
Why?
|
| Mucins | 1 | 2023 | 570 | 0.680 |
Why?
|
| Placenta | 1 | 2024 | 1725 | 0.480 |
Why?
|
| Dry Eye Syndromes | 3 | 2020 | 385 | 0.350 |
Why?
|
| Sequence Analysis, RNA | 3 | 2024 | 2040 | 0.350 |
Why?
|
| Genetic Testing | 1 | 2022 | 3591 | 0.320 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3252 | 0.300 |
Why?
|
| Gene Expression Profiling | 2 | 2022 | 9538 | 0.300 |
Why?
|
| Mucus | 1 | 2023 | 346 | 0.190 |
Why?
|
| Sputum | 1 | 2023 | 517 | 0.180 |
Why?
|
| Glaucoma Drainage Implants | 1 | 2020 | 107 | 0.160 |
Why?
|
| Trabeculectomy | 1 | 2020 | 174 | 0.160 |
Why?
|
| Glaucoma, Angle-Closure | 1 | 2020 | 192 | 0.150 |
Why?
|
| Stress, Physiological | 1 | 2024 | 1408 | 0.140 |
Why?
|
| Cell Cycle | 1 | 2024 | 2932 | 0.130 |
Why?
|
| Welding | 1 | 2016 | 89 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2024 | 4146 | 0.120 |
Why?
|
| Travel | 1 | 2020 | 805 | 0.120 |
Why?
|
| Aftercare | 1 | 2020 | 916 | 0.120 |
Why?
|
| Caudate Nucleus | 1 | 2016 | 391 | 0.120 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2020 | 742 | 0.110 |
Why?
|
| Air Pollutants, Occupational | 1 | 2016 | 406 | 0.110 |
Why?
|
| Shoulder Joint | 1 | 2020 | 746 | 0.110 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2016 | 506 | 0.110 |
Why?
|
| Diabetic Retinopathy | 1 | 2022 | 1300 | 0.100 |
Why?
|
| Dyslipidemias | 1 | 2020 | 873 | 0.100 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 5889 | 0.100 |
Why?
|
| Orthopedics | 1 | 2020 | 906 | 0.090 |
Why?
|
| Models, Genetic | 1 | 2020 | 3447 | 0.090 |
Why?
|
| Orthopedic Procedures | 1 | 2020 | 1279 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2024 | 10474 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 22379 | 0.070 |
Why?
|
| Mice | 3 | 2024 | 82029 | 0.070 |
Why?
|
| Migraine Disorders | 1 | 2019 | 1713 | 0.070 |
Why?
|
| Inflammation | 2 | 2024 | 10873 | 0.070 |
Why?
|
| Software | 1 | 2020 | 4478 | 0.070 |
Why?
|
| Occupational Exposure | 1 | 2016 | 1807 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3251 | 0.060 |
Why?
|
| Phenotype | 1 | 2023 | 16726 | 0.060 |
Why?
|
| Genome-Wide Association Study | 1 | 2024 | 12795 | 0.060 |
Why?
|
| Humans | 13 | 2024 | 768166 | 0.050 |
Why?
|
| Odds Ratio | 3 | 2020 | 9669 | 0.050 |
Why?
|
| Vitreous Hemorrhage | 1 | 2022 | 47 | 0.050 |
Why?
|
| Pregnancy | 1 | 2024 | 30256 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 3833 | 0.050 |
Why?
|
| Animals | 3 | 2024 | 169246 | 0.050 |
Why?
|
| Lost to Follow-Up | 1 | 2020 | 124 | 0.040 |
Why?
|
| Vitrectomy | 1 | 2022 | 392 | 0.040 |
Why?
|
| North Carolina | 1 | 2019 | 329 | 0.040 |
Why?
|
| Arthroplasty | 1 | 2020 | 308 | 0.040 |
Why?
|
| Female | 7 | 2024 | 397192 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2024 | 2131 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2022 | 81762 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 2020 | 1304 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 939 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2024 | 3228 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2020 | 1480 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2020 | 1820 | 0.030 |
Why?
|
| Obesity | 1 | 2016 | 13090 | 0.030 |
Why?
|
| Copper | 1 | 2016 | 368 | 0.030 |
Why?
|
| Young Adult | 4 | 2020 | 60066 | 0.030 |
Why?
|
| Joint Instability | 1 | 2020 | 803 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2022 | 2714 | 0.030 |
Why?
|
| Triglycerides | 1 | 2020 | 2464 | 0.020 |
Why?
|
| Magnesium | 1 | 2016 | 815 | 0.020 |
Why?
|
| Health Services Accessibility | 2 | 2020 | 5520 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2020 | 22291 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 1135 | 0.020 |
Why?
|
| Cholesterol | 1 | 2020 | 2914 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 2403 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2022 | 39348 | 0.020 |
Why?
|
| Reoperation | 1 | 2020 | 4329 | 0.020 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2016 | 1099 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 36743 | 0.020 |
Why?
|
| Middle Aged | 5 | 2020 | 223492 | 0.020 |
Why?
|
| Adult | 5 | 2020 | 223646 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3800 | 0.020 |
Why?
|
| Iron | 1 | 2016 | 1813 | 0.020 |
Why?
|
| Aged | 4 | 2020 | 171504 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 6082 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2020 | 5919 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 16045 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2020 | 8080 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2020 | 4858 | 0.010 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 3415 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 18065 | 0.010 |
Why?
|
| United States | 2 | 2020 | 73039 | 0.010 |
Why?
|
| Prevalence | 1 | 2019 | 15869 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2016 | 4428 | 0.010 |
Why?
|
| Male | 4 | 2020 | 364719 | 0.010 |
Why?
|
| Adolescent | 2 | 2020 | 89169 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2020 | 24315 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 26379 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 18349 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 59629 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 65371 | 0.010 |
Why?
|
Concepts
(98)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(9)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_